Vontobel Holding’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.7K | Buy |
73,300
+15,000
| +26% | +$8.12K | ﹤0.01% | 1093 |
|
|
2025
Q1 | $38.2K | Sell |
58,300
-93,800
| -62% | -$61.5K | ﹤0.01% | 1072 |
|
|
2024
Q4 | $155K | Sell |
152,100
-147,900
| -49% | -$151K | ﹤0.01% | 1027 |
|
|
2024
Q3 | $259K | Buy |
300,000
+241,440
| +412% | +$209K | ﹤0.01% | 950 |
|
|
2024
Q2 | $21K | Hold |
58,560
| – | – | ﹤0.01% | 1061 |
|
|
2024
Q1 | $39.2K | Buy |
58,560
+18,000
| +44% | +$12.1K | ﹤0.01% | 1060 |
|
|
2023
Q4 | $22K | Buy |
40,560
+10,000
| +33% | +$5.43K | ﹤0.01% | 1086 |
|
|
2023
Q3 | $18.3K | Hold |
30,560
| – | – | ﹤0.01% | 1060 |
|
|
2023
Q2 | $39.7K | Sell |
30,560
-40,000
| -57% | -$52K | ﹤0.01% | 1080 |
|
|
2023
Q1 | $124K | Buy |
70,560
+6,000
| +9% | +$10.6K | ﹤0.01% | 1016 |
|
|
2022
Q4 | $203K | Buy |
64,560
+24,000
| +59% | +$75.4K | ﹤0.01% | 996 |
|
|
2022
Q3 | $199K | Buy |
40,560
+20,000
| +97% | +$98.1K | ﹤0.01% | 952 |
|
|
2022
Q2 | $85K | Hold |
20,560
| – | – | ﹤0.01% | 984 |
|
|
2022
Q1 | $119K | Hold |
20,560
| – | – | ﹤0.01% | 1030 |
|
|
2021
Q4 | $154K | Hold |
20,560
| – | – | ﹤0.01% | 1012 |
|
|
2021
Q3 | $185K | Hold |
20,560
| – | – | ﹤0.01% | 1046 |
|
|
2021
Q2 | $246K | Hold |
20,560
| – | – | ﹤0.01% | 985 |
|
|
2021
Q1 | $258K | Hold |
20,560
| – | – | ﹤0.01% | 857 |
|
|
2020
Q4 | $321K | Buy |
+20,560
| New | +$321K | ﹤0.01% | 739 |
|